Never miss a story

Get subscribed to our newsletter


×
Diabetes (Representational image). Wikimedia
  • FDA regulators have already given approval to this device named “MiniMed 670G” for Type 1 diabetes patients who are at least 14 years old
  • A device was developed by Medtronic an Ireland-based device manufacturer to help diabetes patients to manage their blood sugar levels
  • Medtronic is also testing the device on pediatric patients

September 30, 2016: The Food and Drug Administration (FDA) has approved a first-of-a-Kind “artificial pancreas” a device, which was developed by Medtronic to help diabetes patients to manage their blood sugar levels on Wednesday. With the help of this device, patients can easily monitor blood sugar levels and supply insulin.


NewsGram brings to you current foreign news from all over the world.

Type 1 diabetes patients manage their insulin through multiple injections throughout the day or a drug pump that delivers it through a tube. Their own pancreas doesn’t make insulin, a hormone needed to turn food into energy. Due to this, they face increased risks of dangerously high blood-sugar levels, heart disease and many other health problems, reported AP.

This new device is going to be a big relief to the Type 1 diabetes patients.

According to the AP report, FDA regulators have already given approval to this device named “MiniMed 670G” for Type 1 diabetes patients, who are at least 14-years-old. This device consists of a drug pump, a sensor that measures blood sugar and delivering insulin as needed. It wirelessly links up an insulin pump and glucose monitor, allowing patients to partly turn over the process of testing and adjusting their blood sugar levels.

NewsGram brings to you top news around the world today.

After studying the device for three months with more than 120 patients, the Food and Drug Administration has approved it. The study reported no major adverse events such as dangerously low blood sugar, showing that the device is safe for those 14 years and up, regulators said in a release.

Check out NewsGram for latest international news updates.

Medtronic is also testing the device on pediatric patients. One such patient is 13-year-old Jonathan Platt of the Los Angeles area, who is still using his device after the completion of the trial. “For our family, it’s been life-changing,” his mother, Angie Platt said to AP.

She said that after an initial adjustment period, blood sugar imbalances that prompt middle-of-the-night trips to Jonathan’s room have been reduced from several times a night to half a dozen times, a month.

– prepared by Aakash Mandyal of NewsGram. Twitter: @Aakashsen6


Popular

Unsplash

The Microsoft office

Microsoft has disrupted the activities of a China-based hacking group, gaining control of the malicious websites the group used to attack organisations in the US and 28 other countries around the world.

The Microsoft Digital Crimes Unit (DCU) said in a statement that a federal court in Virginia granted its request to seize websites of the hacking group called 'Nickel', enabling the company to cut off Nickel's access to its victims and prevent the websites from being used to execute attacks.

Keep Reading Show less
Unsplash

MediaTek's plans to boost technology democratisation and enable access to disruptive connectivity

Chip manufacturer MediaTek on Monday announced that it is focused on making 2022 a year aimed at rapid growth, business success, substantial expansion in Research and Development capabilities.

MediaTek's plans to boost technology democratisation and enable access to disruptive connectivity with its range of mainstream to flagship 5G chips.

"We at MediaTek are focused on making 2022 a year aimed at rapid growth, business success, and substantial expansion in our R&D capabilities. For 2022, we are focused on further strengthening our presence in India, offering incredible experiences to customers, and supporting the country's technology initiatives with our expertise and collaboration with leading OEMs," Anku Jain, Managing Director, MediaTek India said in a statement.

Follow NewsGram on LinkedIn to know what's happening around the world.

In the flagship segment, MediaTek recently announced the Dimensity 9000 chip, which is a milestone of innovation and a rise to the incredible, built-to-power flagship 5G smartphones in the world, the company claims.

MediaTek Dimensity 9000 features a single Cortex-X2 performance core clocked at 3.05GHz, three Cortex-A710 cores at 2.85GHz and four Cortex-A510 efficiency cores at 1.8GHz.

It packs a 10-core Arm Mali-G710 that takes care of graphics processing, the report said.

Keep Reading Show less
Unsplash

There have already been voices in the US demanding most of the "China concept stocks" be removed from the US.

If the US loses Chinese companies, Wall Street will gradually alienate itself from the world's most prosperous market and the US will no longer be the true global financial centre, Chinese state media claimed.

Didi Chuxing, the Chinese ride-hailing giant, announced on Friday that the company is starting the work of delisting from the New York Stock Exchange (NYSE) and initiating preparations for listing in Hong Kong.

Keep reading... Show less